Centene Corp. (CNC) EVP Kenneth Rone Baldwin Sells 6,000 Shares
Centene Corp. (NYSE:CNC) EVP Kenneth Rone Baldwin sold 6,000 shares of Centene Corp. stock in a transaction dated Monday, October 3rd. The shares were sold at an average price of $66.58, for a total value of $399,480.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Centene Corp. (NYSE:CNC) opened at 61.90 on Thursday. The firm has a market capitalization of $10.57 billion, a price-to-earnings ratio of 23.89 and a beta of 0.94. The company has a 50 day moving average price of $67.54 and a 200-day moving average price of $65.81. Centene Corp. has a 52 week low of $47.36 and a 52 week high of $75.57.
Centene Corp. (NYSE:CNC) last announced its earnings results on Tuesday, July 26th. The company reported $1.29 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.09 by $0.20. Centene Corp. had a return on equity of 14.27% and a net margin of 1.19%. The business had revenue of $10.90 billion for the quarter, compared to analyst estimates of $10.80 billion. During the same quarter last year, the firm earned $0.72 EPS. Centene Corp.’s revenue for the quarter was up 97.9% compared to the same quarter last year. Equities analysts predict that Centene Corp. will post $4.37 earnings per share for the current year.
A number of large investors have recently made changes to their positions in the stock. Robecosam AG purchased a new stake in shares of Centene Corp. during the first quarter worth about $107,000. Duncker Streett & Co. Inc. raised its stake in shares of Centene Corp. by 28.0% in the second quarter. Duncker Streett & Co. Inc. now owns 1,600 shares of the company’s stock worth $114,000 after buying an additional 350 shares in the last quarter. IFP Advisors Inc raised its stake in shares of Centene Corp. by 6.9% in the first quarter. IFP Advisors Inc now owns 1,960 shares of the company’s stock worth $121,000 after buying an additional 127 shares in the last quarter. Quadrant Capital Group LLC raised its stake in shares of Centene Corp. by 11.0% in the second quarter. Quadrant Capital Group LLC now owns 2,170 shares of the company’s stock worth $151,000 after buying an additional 215 shares in the last quarter. Finally, Tompkins Financial Corp raised its stake in shares of Centene Corp. by 243.8% in the second quarter. Tompkins Financial Corp now owns 2,235 shares of the company’s stock worth $159,000 after buying an additional 1,585 shares in the last quarter. 92.92% of the stock is currently owned by institutional investors and hedge funds.
Several equities research analysts recently commented on the company. Leerink Swann reissued a “hold” rating on shares of Centene Corp. in a research note on Tuesday. Credit Suisse Group AG lowered their price target on Centene Corp. from $78.00 to $76.00 and set an “outperform” rating for the company in a research note on Wednesday. Cantor Fitzgerald reissued a “buy” rating on shares of Centene Corp. in a research note on Thursday, September 29th. Evercore ISI assumed coverage on Centene Corp. in a research note on Thursday, September 22nd. They issued a “buy” rating and a $79.00 price target for the company. Finally, Wedbush reissued an “outperform” rating and issued a $85.00 price target on shares of Centene Corp. in a research note on Wednesday, September 7th. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $80.76.
Centene Corp. Company Profile
Centene Corporation is a diversified healthcare company that provides programs and services to government sponsored healthcare programs. The Company also provides education and outreach programs to inform and assist members in accessing appropriate healthcare services. The Company operates through two segments.
Receive News & Stock Ratings for Centene Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene Corp. and related stocks with our FREE daily email newsletter.